Duke Cancer Institute /ID# 247236

Durham, North Carolina 27710

0 studies enrolling now · 1 studies all time

What they study most

Advanced Solid Tumors, Colorectal Cancer, Gastroesophageal Adenocarcinoma, Non-Small Cell Lung Cancer

Studies at this site

• Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Advanced Solid Tumors Receiving Intravenous (IV) ABBV-400 as Monotherapy and in Combination With IV Bevacizumab — Running, not enrolling